Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments

Contingent Liabilities and Commitments (Details)

v3.21.2
Contingent Liabilities and Commitments (Details)
€ in Thousands, $ in Thousands
1 Months Ended 6 Months Ended 12 Months Ended
Jun. 28, 2021
EUR (€)
Mar. 16, 2021
USD ($)
Jun. 30, 2021
USD ($)
Dec. 31, 2020
USD ($)
Contingent Liabilities and Commitments (Details) [Line Items]        
Upfront payments € 250 $ 2,250    
Upfront payments, additional   $ 40,450    
Royalty payments, percentage   17.50%    
Contract liabilities     $ 4,343 $ 2,490
Recognized revenues     398  
Ewopharma Agreement [Member]        
Contingent Liabilities and Commitments (Details) [Line Items]        
Contract liabilities       $ 265
Recognized revenues     $ 133